Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction

NATerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 11, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Non Small Cell Lung Cancer
Interventions
PROCEDURE

Photodynamic Therapy

Participants on this arm will be treated with photodynamic therapy. PDT is a two-stage process. The first stage of PDT is the intravenous injection of porfimer sodium (Photofrin) administered as a single slow intravenous injection over 3 to 5 minutes. The second stage involves the application of laser light to the tumor by bronchoscopy.

PROCEDURE

Argon Plasma Coagulation

"Participants on this arm will be treated with argon plasma coagulation. A flexible probe housing a wire delivers high-frequency, high-voltage electric current to a monopolar tungsten electrode present at the tip of the probe. Argon gas flows through the probe, and is charged or ionized to produce plasma as it flows around the tungsten electrode. Electric current flows through the plasma to the nearest tissue, and heat is produced as it passes through the tissue. Increased resistance created by coagulated tissue impairs the flow of electric current, and keeps the ablation depth to 1 to 2 mm."

Trial Locations (1)

32608

University of Florida, Gainesville

Sponsors
All Listed Sponsors
collaborator

Concordia Laboratories Inc.

INDUSTRY

lead

University of Florida

OTHER